Research published in the Journal of Alzheimer's Disease suggests findings could transform emergency protocols for the 2.5 ...

ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and ...

New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A shared molecular signature of Alzheimer’s appears across populations once studied in isolation. Alzheimer's disease (AD) ...

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

People can add more broccoli to their diet by tossing a few florets it into a stir fry with chicken or tofu, finely chopping ...

Conventional Alzheimer’s therapies often target only a single pathological feature, such as amyloid aggregation or oxidative ...

In this webinar, Jonathan Schott and Alex Forrest-Hay will showcase how new biomarker assays for brain-derived pTau217 ...